Galapagos NV
GLPG
#4540
Rank
HK$17.44 B
Marketcap
HK$264.69
Share price
-0.73%
Change (1 day)
47.64%
Change (1 year)

Market capitalization of Galapagos NV (GLPG)

Market cap: HK$17.44 Billion

As of February 2026 Galapagos NV has a market cap of HK$17.44 Billion. This makes Galapagos NV the world's 4540th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Galapagos NV from 2008 to 2026

End of year Market Cap

Year Marketcap Change
2026HK$17.44 B3%
2025HK$16.93 B21.26%
2024HK$13.96 B-33.24%
2023HK$20.92 B-8.36%
2022HK$22.82 B-19.86%
2021HK$28.48 B-43.25%
2020HK$50.19 B-52.29%
2019HK$105.21 B167.69%
2018HK$39.30 B4.75%
2017HK$37.52 B62.38%
2016HK$23.10 B20.95%
2015HK$19.10 B331.6%
2014HK$4.42 B-8.92%
2013HK$4.86 B10.95%
2012HK$4.38 B58.12%
2011HK$2.77 B-16.32%
2010HK$3.31 B67.51%
2009HK$1.97 B148.88%
2008HK$0.79 B

End of Day market cap according to different sources

On Jan 31st, 2026 the market cap of Galapagos NV was reported to be:

HK$17.44 Billion
by Nasdaq info icon info icon
HK$17.44 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Johnson & Johnson
JNJ
HK$4.277 T 24,423.61%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
HK$1.486 T 8,420.68%๐Ÿ‡บ๐Ÿ‡ธ USA
AbbVie
ABBV
HK$3.079 T 17,554.11%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
HK$892.64 B 5,017.59%๐Ÿ‡ซ๐Ÿ‡ท France
Merck
MRK
HK$2.151 T 12,236.80%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
HK$2.247 T 12,783.66%๐Ÿ‡ฌ๐Ÿ‡ง UK
GSK plc
GSK
HK$814.75 B 4,571.07%๐Ÿ‡ฌ๐Ÿ‡ง UK
Fortress Biotech
FBIO
HK$0.75 B-95.69%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
HK$305.47 B 1,651.30%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel